Novo Seeds co-led a $61.7m round for the oncology therapy developer with Ysios Capital, following a Novo Nordisk Foundation grant.

Prosus Ventures has reinvested in the commerce services provider through a round valuing it at $400m.

The pain management platform developer has now raised at least $125m altogether, after pulling in series C funding from investors including Optum.

JLL and New World Development have participated in a series C round for the construction imaging technology provider, which has increased its total funding to over $88m.

Coinbase and Genies both participated in a series B round that pushed the blockchain infrasructure provider's valuation past $500m.

Applied Ventures helped assay provider Ultivue close a $50m round while clean energy producer Sunseap has followed a $72m series D4 round with more corporate funding.

Lilly Asia Ventures co-led a $61.7m round for the endoscopy technology developer that was also backed by Medtronic.

Renal care provider InterWell Health and skincare product manufacturer Make Essence both raised approximately $46m while Salesforce-backed JazzHR agreed a merger.

China Medical System and a WuXi Biologics industry investment fund were among the participants in the antibody therapy developer's $69.3m series A round.

The Intel Capital-backed community engagement platform developer took its total funding to $67m with the close of its series B round.